Dimpless : scientific studies

The efficacy of Dimpless on cellulite and fat metabolism disorders has been demonstrated in two Gold standard clinical studies carried out on women aged between 25 and 50.
Results have shown that thanks to its targeted action on subcutaneous fat, Dimpless is able not only to improve skin appearance and reduce cellulite, but also to accelerate inch loss.
Visual cellulite scoring using a validated scale showed a significant 10% reduction in cellulite after just 1 month of supplementation.
Several measurements of skin folds were also taken, in areas specifically concerned by fat storage and cellulite, namely the buttocks (gluteal fold) and thighs (femoral fold).
The results showed a reduction in gluteal and femoral folds versus Placebo, with -23% and -28% respectively after 3 months of supplementation.
Complementary measurements were taken on 2 areas specifically concerned by fat storage but not cellulite, namely the waist and hips.
The results showed a reduction in hip and waist circumference, down 40% and 46% respectively, after 3 months of supplementation.
While metabolic disorders can induce adipocyte hypertrophy and connective tissue fibrosis, Dimpless® has been shown to significantly improve adipose tissue morphology.
Following supplementation, both fat cell size and fibrosis were reduced by more than 50% compared to the control.
Fat storage is known to result in altered oxidative status.
The expansion of adipose tissue is associated with both an induction of free radicals via activation of NADPH oxidase, and a decrease in the expression of endogenous antioxidant enzymes.
Dimpless® has demonstrated its ability not only to normalize the expression of SOD, catalase and glutathione peroxidase, but also to restore lipolysis to a healthy level.
Despite similar weight loss in the Dimpless® and Placebo groups, these results were only observed in the Dimpless® group,
confirming its action not only on visible cellulite, but more generally on subcutaneous fatty tissue, accelerating centimetre loss.
Clinical trial of a natural and bioactive melon SuperOxide Dismutase
(SOD B Dimpless®) on cellulite.
Randomisée, en double aveugle, versus Placebo
41 femmes/31 – 50 ans/ 40mg(480 UI SOD)/2 mois
Randomisée, en double aveugle, versus Placebo
35 femmes en surpoids (25<IMC<31)/
25-50 ans/40mg (480 UI SOD)/3 mois